The urokinase plasminogen activator receptor is highly expressed and its gene is amplified in about 50% of pancreatic ductal adenocarcinomas; this last feature is associated with worse prognosis. This evidence concerns the gene PLAUR and pancreatic ductal adenocarcinoma.